| Autor: |
Gheorghe L; Department of Radiology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.; Radiology Clinic, 'St. Spiridon' County Clinical Emergency Hospital, 700111 Iasi, Romania., Nemteanu R; Medical I Department, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.; Institute of Gastroenterology and Hepatology, Saint Spiridon Hospital, 700111 Iasi, Romania., Clim A; Medical I Department, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania., Botnariu GE; Diabetes, Nutrition and Metabolic Diseases Department, University of Medicine and Pharmacy 'Gr. T. Popa', 700115 Iasi, Romania., Costache II; Medical I Department, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.; Cardiology Clinic, 'St. Spiridon' County Clinical Emergency Hospital, 700111 Iasi, Romania., Plesa A; Medical I Department, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.; Institute of Gastroenterology and Hepatology, Saint Spiridon Hospital, 700111 Iasi, Romania. |
| Abstrakt: |
Over the past 100 years, cardiovascular disease (CVD) has become a leading cause of mortality and morbidity in developed countries, and similar trends have occurred for chronic liver disease. Subsequent research also indicated that people with non-alcoholic fatty liver disease (NAFLD) had a twofold increased risk of CV events and that this risk was doubled in those with liver fibrosis. However, no validated CVD risk score specific for NAFLD patients has yet been validated, as traditional risk scores tend to underestimate the CV risk in NAFLD patients. From a practical perspective, identifying NAFLD patients and assessing severity of liver fibrosis when concurrent atherosclerotic risk factors are already established may serve as an important criterion in new CV risk scores. The current review aims to assess current risk scores and their utility for the prediction of CV events among patients with NAFLD. |
